Nexgel, Inc.
NXGL- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001468929
No open-market purchases or sales by Nexgel, Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $293.0K in total; no superinvestor holds it.
Other share classesNXGLW
Q4 2024 vs. Q3 2024
How the institutions holding Nexgel, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 12 | 15 | +3 |
| Shares | 228.6K | 465.3K | +236.7K (+103.5%) |
| Value | $589.8K | $2.08M | +$1.49M (+251.8%) |
New holders (5)
Institutions that held Nexgel, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| State Street Corp | 17,259 | $77.0K | 0.00% |
| Two Sigma Securities, LLC | 12,035 | $53.7K | 0.01% |
| IFP Advisors, Inc | 11,000 | $49.1K | 0.00% |
| Virtu Financial LLC | 10,786 | $48.0K | 0.00% |
| SBI Securities Co., Ltd. | 607 | $2.71K | 0.00% |
Sold out (2)
Institutions that held Nexgel, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Northeast Financial Group, Inc. | 31,848 | $82.2K |
| UBS Group AG | 2,744 | $7.08K |